BIOPHEN Heparin Anti-Xa (2 Stages)
For Research Use Only in the United States and Canada
Clotting, Deficient Plasmas, & Chromogenic Assays products are available worldwide
Chromogenic anti-Xa method for measuring homogeneously heparin in purified systems or in plasma using a two stage method. First, Factor Xa, in excess, is inhibited by heparin in presence of AT III, also in excess (and provided in the assay), then the residual Xa activity is measured by its activity on the specific substrate SXa-65.
|
Assay characteristics
|
Kit components
|
Applications
|
|
Total Assay Time: < 5 min.
Detection Threshold: 0.02 IU/mL
Dynamic Range: 0.0 to 4.0 IU/mL
Intra-Assay CV: < 3%
Inter-Assay CV: < 5%
|
R1: 2x2.5 mL Factor Xa
R2: 2x2.5 mL AT III
R3: 2x2.5 mL Factor Xa substrate (SXa-65)
R4: 2x25 mL Sample Diluent
|
Conventional chromogenic inhibitory assay for the measurement of Anti-Xa Heparin (UFH and LMWH) activity in purified systems or plasma.
|
Streamline laboratory procedures! Click here for ready-to-use reagents and
buffers, from Medicago AB. Available in tablets and pouches!
| INFORMATION |
| SKU ID # |
Packaging |
Package Inserts |
MSDS |
Adaptations |
Price |
| A221010 |
2x50 tests |
|
|
|
$350.00 |
|
|
Back to Chromogenic assays
|
